Indole compounds, process for producing the same and drugs...

Details Indole compounds, process for producing the same and drugs... Indole compounds, process for producing the same and drugs...

2006-12-26

2006-12-26

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S414000, C514S415000, C544S105000, C548S454000, C548S455000

Reexamination Certificate

active

07153852

ABSTRACT:
Indole derivatives represented by formula (I)wherein all symbols represent the same as that in specification), production methods thereof, and DP receptor antagonist comprising them as active ingredients.Since the compounds of formula (I) binds and antagonizes to DP receptor, they are useful for the prevention and/or treatment against allergic diseases, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis.

REFERENCES:
patent: 5234942 (1993-08-01), Bernstein et al.
patent: 5290788 (1994-03-01), Stevens et al.
patent: 5811439 (1998-09-01), Ogawa et al.
patent: 6743793 (2004-06-01), Torisu et al.
patent: 2004/0180885 (2004-09-01), Torisu et al.
patent: 2005/0004097 (2005-01-01), Torisu et al.
patent: 780389 (1977-06-01), None
patent: 458342 (1991-11-01), None
patent: 509400 (1992-10-01), None
patent: 1 262 475 (2002-12-01), None
patent: WO 01/66520 (2001-09-01), None
patent: WO 200166520 (2001-09-01), None
patent: WO 2004037788 (2004-05-01), None
Torisu, K., et al., “Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists,” Bioorganic & Medicinal Chemistry, vol. 12(20), pp. 5361-5378 (Oct. 2004) esp. p. 5362, Figure 1, compounds 1, 2, 4, 5a-i, 9a-i.
Torisu, K., et al., “Discovery of orally active prostaglandin D2 receptor anagonists,” Bioorganic & Medicinal Chemistry Letters, vol. 14(19), pp. 4891-4895 (Oct. 2004), especially at p. 4893, Table 2, compounds 2d, 3g-i.
Torisu, K., et al., “Development of prostaglandin D2 receptor antagonist,” Bioorganic & Medicinal Chemistry, vol. 12(17), pp. 4685-4700 (Sep. 2004); esp. at p. 4690, compounds 3g-3k.
MacKay, Ian and Rosen, Fred, “Autoimmune Diseases,” N. Engl. J. Med., vol. 345(5), pp. 340-350 (Aug., 2001), especially at p. 345, Figure 2, lines 1, 2.
O'Dell, James, “Therapeutic Strategies for Rheumatoid Arthritis,” N. Engl. J. Med., vol. 350, pp. 2591-2602 (Jun. 2004)(strategies for treating Rheumatoid Arthritis with TNF-α inhibitors).
Prokunina and Riquelme, M., “The genetic basis of systemic lupus erythematosus—knowledge of today and thought for tomorrow,” Human Molecular Genetics, vol. 13(Rev. Issue 1), pp. R143-R148 (2004), esp. at p. R144 (PD-1 Pathway), p. R145 (IFN Pathway).
Rahman, A., “Autoantibodies, lupus and science of sabotage,” Rheumatology, vol. 43(11), pp. 1326-1336 (2004), especially at p. 1326, col. 2, lines 9-15.

Affiliated with

Also associated with

Rating

Indole compounds, process for producing the same and drugs... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indole compounds, process for producing the same and drugs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indole compounds, process for producing the same and drugs... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3705540